Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, BMS, Compugen, Cytodyn, Dare, Faron, FSD, Gemoab, Kala, Retrophin, Revolution, Terns, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: PreludeDx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Biocryst, Grindeks, Hansa, Idera, Kancera, Matinas, Palvella.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neovasc, Neurometrix Sphingotec.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Arch, Auris, Debiopharm, Dynacure, Psioxus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Inflammatix, Ocutrx Vision Technologies.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Allergan, American Brivision, Chugai, Cytodyn, Delmar, Discgenics, Editas, Innovent, Moderna, Oncolys.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Apeiron Biologics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Cernostics, Integrity Implants, Moleculight, Pixium Vision, Quanta, Sensus Healthcare, Treace Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arrowhead, Avita, Bioarctic, CNS, Eisai, Mina, PDC*Line, Neuraly, Prevail, Puretech, Targovax, VBI.